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Genes and
Environment: 
A SNPshot
Have you ever heard someone try to dispel
concern about their smoking by describing
elderly relatives who were lifelong smokers?
This gambit usually fails, but there actually
is something to the excuse. Increasingly,
researchers are uncovering the extent to
which genes control susceptibility and vul-
nerability to environmental health hazards,
including cigarette smoke, toxic chemicals,
alcohol, and more.
To understand why individuals react
differently to the same chemicals requires
analysis of differences in their genetic
makeup. Single-nucleotide polymor-
phisms (SNPs), which are common
one-letter variations in the DNA
sequence occurring in at least 1% of
the population (anything rarer is a
mutation), are the simplest differences
to examine on the wide scale, agreed
participants at “Genetic Variation and
Gene–Environment Interaction in
Human Health and Disease,” a semi-
nar held 16 April 2003 at the NIH
campus in Bethesda, Maryland. The
NIEHS, the National Human Genome
Research Institute, and the National
Institute on Alcohol Abuse and
Alcoholism sponsored the seminar,
which was part of an NIH conference
marking the 50th anniversary of the
discovery of the chemical structure of
DNA and the recently completed
sequencing of the human genome. 
The Search for SNPs
Studying cancer-causing agents in the
environment is difficult due to chal-
lenges such as the near-impossibility of
determining a person’s diet or occupa-
tional exposures over many years. SNPs, on
the other hand, are abundant and traceable,
said seminar participant Martyn Smith, a
toxicologist at the University of California,
Berkeley, School of Public Health and
director of the university’s NIEHS-spon-
sored Environmental Health Sciences
Center. Functional SNPs are an intriguing
topic of study, Smith said, because they are
common and are likely to explain the
majority of people’s susceptibility.
A typical gene of 30,000 base pairs has
150 SNPs in it, noted Deborah Nickerson,
a geneticist at the University of Washington
in Seattle. Most SNPs are “silent,” and thus
have little or no effect on human health.
But some greatly influence disease risk.
SNPs near one another in the genome can
be related, forming blocks in a gene and
potentially making it easier to trace suscepti-
bilities in the general population. The
BRCA1 breast cancer gene has just such
blocks, Nickerson discovered only days prior
to the seminar. Discovering such blocks will
make it easier for researchers to understand
the role of BRCA1 in breast cancer develop-
ment in women who don’t have rare inherit-
ed mutations in this gene, she said. 
Smith and collaborators in Leeds,
England, are looking for SNPs that make
humans more susceptible to leukemia. Most
cases of leukemia can’t be explained by
environmental exposures or heredity alone,
and instead arise from gene–environment
interactions, he told seminar participants.
In the early 1990s, scientists discovered
that a SNP on the NQO1 gene reduces the
activity of the enzyme it regulates and
increases the risk of benzene-induced
leukemia. This finding led Smith and col-
leagues to propose that chemicals that
cause oxidative stress and that are detoxi-
fied by NQO1, such as benzene and
flavonoids in high doses, may increase the
risk of myeloid leukemia. They have also
suggested that low folate intake increases
the risk of lymphocytic leukemia in both
adults and children, whereas certain SNPs
in folate-metabolizing genes decrease the
risk. Smith and his colleagues are also
looking at SNPs in genes involved in apop-
tosis and DNA repair in relation to
leukemia risk, and are further expanding
their research to the study of lymphoma.
Clement Furlong, a geneticist at the
University of Washington in Seattle,
reported that some people are more sensi-
tive to insecticides and possibly nerve agents
because of genetic variability in the gene
that regulates production of the enzyme
paraoxonase (PON1). PON1 oxidizes
lipids, metabolizes organophosphates, and
activates or inactivates medications includ-
ing statins, glucocorticoids, and antibiotics.
Although children have attained their
life-time level of the enzyme by about 15
months of age, PON1 levels and efficiency
vary considerably from person to person,
Furlong said. He cited research published
in the 15 June 1999 issue of Toxicology
and Applied Pharmacology showing that
veterans who suffered from Gulf War syn-
drome had low PON1 levels. However,
studies have shown that injecting purified
PON1 into mice without the PON1 gene
protects them against chemical assault.
Furlong is confident that injections of
engineered recombinant PON1 will
someday be similarly used to detoxify
humans who have been exposed to
organophosphates.
Major Advances in the Field
The hunt for genetic susceptibility to
many chemicals and diseases has been
made possible by major advances in
molecular methods that enable
researchers to rapidly sequence whole
genomes and associate SNPs with specif-
ic diseases. “We spent many, many years
uncovering about a dozen polymor-
phisms in the [PON1] gene,” Furlong
said at a press conference following the
seminar. But thanks to revolutionary
new technologies, in just the last couple
of months, Nickerson and her group
have identified more than 150 addition-
al PON1 polymorphisms. In a matter of
days, she sequenced the entire PON1
gene from four individuals suspected of
having sequence variations and then
identified those variations, Furlong said,
revealing one coding-region SNP that affects
the efficiency of detoxication of some chemi-
cals and other noncoding-region SNPs that
affect PON1 plasma levels.
Nickerson’s group in Seattle is part of
the NIEHS Environmental Genome Project
(http://www.niehs.nih.gov/envgenom/
home.htm), a national effort to identify
genetic variations among individuals that
make them more vulnerable to environ-
mental agents. The Seattle researchers are
resequencing 554 environmentally respon-
sive genes taken from 450 individuals and
creating a database of SNPs in those genes.
As of April 2003, they had resequenced
214 of the genes. 
At the postseminar press conference,
NIEHS director Kenneth Olden announced
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the completion of the first phase of the
Environmental Genome Project. Research
in this phase focused on finding common
sequence variations in human genes
involved in DNA repair and cell cycle path-
ways. Future goals involve studying apop-
tosis, homeostasis, and drug-metabolizing
genes, all of which are thought to play a
role in vulnerability to environmental
exposure. –Tina Adler 
100th Research
Brief Published
The NIEHS/U.S. Environmental Protection
Agency Superfund Basic Research Program
(SBRP) reached an important milestone in
April 2003 with the release of its 100th
Research Brief. Since their
inception in 1997, these
publications have been a
key component of the
SBRP’s efforts to dis-
seminate its latest find-
ings and demonstrate
how environmental health
science and remediation
research contribute to reducing human
health risk and improving decision making
for hazardous site cleanups.
Each Research Brief summarizes signifi-
cant peer-reviewed findings from SBRP-
funded research, translating the science
into language appropriate for diverse audi-
ences. The 100th issue provides an histori-
cal overview of the briefs and categorizes
the first 99 issues by research area. 
The briefs are distributed via e-mail on
the first Wednesday of each month to
more than 2,600 scientists in 27 countries.
Subscribers include federal and state gov-
ernment employees, academicians, remedi-
ation and engineering professionals, and
advocacy groups.
Throughout the year, SBRP staff review
materials submitted by the program’s 19
grantee universities to select topics for
inclusion in the Research Briefs. The staff
also regularly search the scientific literature
to identify late-breaking advances of inter-
est to the briefs’ readership. SBRP staff
envision using the Research Briefs as a
model for other communication efforts,
possibly developing briefs in a format
specifically for lay audiences.
The Research Briefs as well as subscrip-
tion information are available at http://
www-apps.niehs.nih.gov/sbrp/RB2000/
RB.cfm. Up-to-date listings by research area
are located at http://www-apps.niehs.
nih.gov/sbrp/RB2000/rbcategories.htm.
–Erin E. Dooley
Headliners Genetics
A New Target of DNA Instability: Repeat Expansions
Potaman VN, Bissler JJ, Hashem VI, Oussatcheva EA, Lu L, Shlyakhtenko LS, et al.
2003. Unpaired structures in SCA10 (ATTCT)n•(AGAAT)n repeats. J Mol Biol
326:1095–1111.
Genes in normal individuals contain short lengths of trinucleotide repeats in
which a combination of nucleotides, the building blocks of DNA, are repeat-
ed several times. Such “repeats” usually repeat themselves fewer than 30
times, but research has identified 18 human genetic diseases associated with
expansion of the number of these repeats, sometimes into the thousands.
Fragile X syndrome, myotonic dystrophy, and Huntington disease are a few
of these devastating diseases, which become increasingly severe and have
earlier onsets in successive generations, a process known as anticipation.
Scientists have theorized that if the cause of the repeat expansion can be dis-
covered, there is hope for preventing it from occurring. 
NIEHS grantee Richard R. Sinden and colleagues at Texas A&M
University recently discovered a unique repeat associated with spinocerebel-
lar ataxia type 10 (SCA10), a disease characterized by seizures and lack of
muscle control. The repeat is made up of 10 nucleotides in the sequence
(ATTCT)n•(AGAAT)n. Normally this sequence repeats 10–22 times. People
with SCA10 may have as many as 4,500 copies of this sequence. 
The researchers studied the structural properties of this repeat cloned in
circular plasmids. The (ATTCT)n•(AGAAT)n sequence is unique among
expanding repeat sequences in that it has a very high content of A+T base
pairs. The high A+T content is a feature of DNA sequences that form
unpaired structures known as DNA unwinding elements, or base unpairing
regions. The Texas researchers demonstrated that the (ATTCT)n•(AGAAT)n
repeat does indeed unpair, leaving the DNA strands accessible for interaction
with other molecules and thereby acting as a false site of DNA replication.
The researchers hypothesize that if (ATTCT)n•(AGAAT)n and other DNA
repeats act as strong origins of replication, “then anomalous and fractious
replication may lead to amplification and expansion.”
Although it remains to be seen if repeats associated with other expan-
sion-related diseases support incorrect DNA replication initiation, this finding
gives researchers a new target on which to focus, and may lead to further
discoveries on how to prevent and treat genetic disease. –Jerry Phelps
NIEHS-Supported Research
–DNA unpairing